nach oben

Erschienen in:

22.10.2018 | Original Communication

Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status

verfasst von: Christian Lunetta, Andrea Lizio, Lucio Tremolizzo, Massimiliano Ruscica, Chiara Macchi, Nilo Riva, Patrick Weydt, Ettore Corradi, Paolo Magni, Valeria Sansone

Erschienen in: Journal of Neurology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The progression of amyotrophic lateral sclerosis (ALS) leads to a decline of the nutritional status that represents an independent prognostic factor for survival. Recent studies recognize the muscle tissue as an endocrine organ able to release several molecules, called myokines. Among them, irisin seems to be involved in the regulation of metabolism, body weight and development and function of the nervous system.

Objectives

(1) To evaluate irisin serum levels in patients with ALS, with comparison to healthy subjects; (2) to assess the possible association of circulating irisin levels of ALS patients with the metabolic status, clinical and biochemical features.

Methods

We performed an observational, cross-sectional study in 50 ALS patients and 32 age- and sex-comparable healthy controls. Patients underwent to a complete set of neurological, pulmonary and nutritional evaluations. Serum irisin concentration was measured by enzyme immunoassay. According to indirect calorimetry, ALS patients were divided into a normo-metabolic patient group (n = 24) and a hyper-metabolic patient group (n = 26).

Results

ALS patients showed significantly higher serum irisin levels compared to healthy subjects (51.0 ± 37.8 vs 13.1 ± 2.2 ng/mL, p < 0.0001). Hyper-metabolic ALS patients displayed higher serum irisin levels compared to normo-metabolic ALS patients and healthy controls (p < 0.0009 and p < 0.0001, respectively). Serum irisin levels showed significant association with the ALSFRS-R (β=-1.18, p = 0.042), Forced Vital Capacity (β = − 0.64, p = 0.013), Fat Mass (β=-1.44, p = 0.034), pCO₂ arterial blood levels (β = 2.67, p = 0.003), HCO₃⁻ arterial blood levels (β = 5.44, p = 0.001) and Free Fat Mass (β = 1.07, p = 0.025) adjusted for sex, age and metabolic status.

Conclusions

ALS patients with impaired metabolic status showed higher serum irisin levels compared to normo-metabolic ALS patients and healthy subjects. Irisin levels were also negatively correlated with the extent of functional and respiratory impairment, due to as yet unknown causes, being more elevated in patients with greater disability.

Kiernan MC, Vucic S, Cheah BC et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942–955. https://doi.org/10.1016/S0140-6736(10)61156-7 CrossRefPubMed

Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P (1999) Nutritional status is a prognostic factor for survival in ALS patients. Neurology 53:1059–1063CrossRefPubMed

Marin B, Desport JC, Kajeu P et al (2011) Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 82:628–634. https://doi.org/10.1136/jnnp.2010.211474 CrossRefPubMed

Bouteloup C, Desport JC, Clavelou P et al (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256:1236–1242. https://doi.org/10.1007/s00415-009-5100-z CrossRefPubMed

Desport JC, Preux PM, Magy L et al (2001) Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 74:328–334CrossRefPubMed

Desport JC, Torny F, Lacoste M, Preux PM, Couratier P (2005) Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis 2:202–207. https://doi.org/10.1159/000089626 CrossRefPubMed

Steyn FJ, Ioannides ZA, van Eijk RPA et al (2018) Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2017-317887 CrossRefPubMed

Jésus P, Fayemendy P, Nicol M et al (2018) Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur J Neurol 25:97–104. https://doi.org/10.1111/ene.13468 CrossRefPubMed

Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P (2000) Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 1:91–96CrossRefPubMed

10.

Febbraio MA, Pedersen BK (2005) Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev 33:114–119CrossRefPubMed

11.

Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457–465. https://doi.org/10.1038/nrendo.2012.49 CrossRefPubMed

12.

Boström P, Wu J, Jedrychowski MP et al (2012) A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–468. https://doi.org/10.1038/nature10777 CrossRefPubMedPubMedCentral

13.

Brenmoehl J, Albrecht E, Komolka K et al (2014) Irisin is elevated in skeletal muscle and serum of mice immediately after acute exercise. Int J Biol Sci 10:338–349. https://doi.org/10.7150/ijbs.7972 CrossRefPubMedPubMedCentral

14.

Huh JY, Siopi A, Mougios V, Park KH, Mantzoros CS (2015) Irisin in response to exercise in humans with and without metabolic syndrome. J Clin Endocrinol Metab 100:E453–E457. https://doi.org/10.1210/jc.2014-2416 CrossRefPubMed

15.

Huh JY, Mougios V, Kabasakalis A et al (2014) Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation. J Clin Endocrinol Metab 99:E2154–E2161. https://doi.org/10.1210/jc.2014-1437 CrossRefPubMed

16.

Norheim F, Langleite TM, Hjorth M et al (2014) The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J 281:739–749. https://doi.org/10.1111/febs.12619 CrossRefPubMed

17.

Wrann CD, White JP, Salogiannnis J et al (2013) Exercise induces hippocampal BDNF through a PGC 1α/FNDC5 pathway. Cell Metab 18:649–659. https://doi.org/10.1016/j.cmet.2013.09.008 CrossRefPubMedPubMedCentral

18.

Zhang J, Zhang W (2016) Can irisin be a linker between physical activity and brainfunction? Biomol Concepts 7:253–258. https://doi.org/10.1515/bmc-2016-0012 CrossRefPubMed

19.

Liu JJ, Wong MD, Toy WC et al. (20123) Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 27:365–369. https://doi.org/10.1016/j.jdiacomp.2013.03.002 CrossRefPubMed

20.

Pardo M, Crujeiras AB, Amil M et al (2014) Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol 2014:857270. https://doi.org/10.1155/2014/857270 CrossRefPubMedPubMedCentral

21.

Andersen PM, Borasio GD, Dengler R et al (2005) EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 12:921–938. https://doi.org/10.1111/j.1468-1331.2005.01351.x CrossRefPubMed

22.

Brooks BR, Miller RG, Swash M, Munsat TL (2000) World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299CrossRefPubMed

23.

Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21CrossRefPubMed

24.

Harris JA, Benedict FG (1918) A Biometric Study of Basal Metabolism in Man. Proc Natl Acad Sci USA 4:370–373CrossRefPubMedPubMedCentral

25.

Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138:923–936CrossRefPubMed

26.

Copper A, Weekes TJ (1983) Data, models, and statistical analysis, Rowman & Littlefield. ISBN: 0-389-20383-1, pp 50–51

27.

Mitsumoto H, Hanson MR, Chad DA (1988) Amyotrophic lateral sclerosis. Recent advances in pathogenesis and therapeutic trials. Arch Neurol 45:189–202CrossRefPubMed

28.

Zhang RZ, Gascon R, Miller RG et al (2005) Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol 159:215–224. https://doi.org/10.1016/j.jneuroim.2004.10.009 CrossRefPubMed

29.

Appel SH (2006) Is ALS a systemic disorder? Evidence from muscle mitochondria. Exp Neurol 198:1–3. https://doi.org/10.1016/j.expneurol.2005.12.025 CrossRefPubMed

30.

Wong M, Martin LJ (2010) Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet 19:2284–2302. https://doi.org/10.1093/hmg/ddq106 CrossRefPubMedPubMedCentral

31.

Ehinger JK, Morota S, Hansson MJ, Paul G, Elmér E (2015) Mitochondrial dysfunction in blood cells from amyotrophic lateral sclerosis patients. J Neurol 262:1493–1503. https://doi.org/10.1007/s00415-015-7737-0 CrossRefPubMed

32.

Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffl er JP (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 101:11159–11164. https://doi.org/10.1073/pnas.0402026101 CrossRefPubMedPubMedCentral

33.

Funalot B, Desport JC, Sturtz F, Camu W, Couratier P (2009) High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:113–117. https://doi.org/10.1080/17482960802295192 CrossRefPubMed

34.

Vaisman N, Lusaus M, Nefussy B et al (2009) Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs? J Neurol Sci 279:26–29. https://doi.org/10.1016/j.jns.2008.12.027 CrossRefPubMed

35.

Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis/Riluzole Study Group II. Lancet 347:1425–1431CrossRefPubMed

36.

Wijesekera LC, Leigh PN (2009) Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4:3. https://doi.org/10.1186/1750-1172-4-3 CrossRefPubMedPubMedCentral

37.

Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ (1996) Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 63:130–137CrossRefPubMed

38.

Chiang PM, Ling J, Jeong YH, Price DL, Aja SM, Wong PC (2010) Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Natl Acad Sci USA 107:16320–16324. https://doi.org/10.1073/pnas.1002176107 CrossRefPubMedPubMedCentral

39.

Xu YF, Gendron TF, Zhang YJ et al (2010) Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 30:10851–10859. https://doi.org/10.1523/JNEUROSCI.1630-10.2010 CrossRefPubMedPubMedCentral

40.

Crugnola V, Lamperti C, Lucchini V et al (2010) Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Arch Neurol 67:849–854. https://doi.org/10.1001/archneurol.2010.128 CrossRefPubMed

41.

Echaniz-Laguna A, Zoll J, Ribera F et al (2002) Mitochondrial respiratory chain function in skeletal muscle of ALS patients. Ann Neurol 52:623–627. https://doi.org/10.1002/ana.10357 CrossRefPubMed

42.

Echaniz-Laguna A, Zoll J, Ponsot E et al (2006) Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp Neurol 198:25–30. https://doi.org/10.1016/j.expneurol.2005.07.020 CrossRefPubMed

43.

Lanfranconi F, Ferri A, Corna G et al (2017) Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in Amyotrophic Lateral Sclerosis during exercise. Sci Rep 7:2951. https://doi.org/10.1038/s41598-017-02811-z CrossRefPubMedPubMedCentral

44.

Zhao W, Varghese M, Yemul S et al (2011) Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1a) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol Neurodegener 6:51. https://doi.org/10.1186/1750-1326-6-51 CrossRefPubMedPubMedCentral

45.

Da Cruz S, Parone PA, Lopes VS et al (2012) Elevated PGC-1 α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab 15:778–786. https://doi.org/10.1016/j.cmet.2012.03.019 CrossRefPubMedPubMedCentral

46.

Aronis KN, Moreno M, Polyzos SA et al (2015) Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events. Int J Obes (Lond) 39:156–161. https://doi.org/10.1038/ijo.2014.101 CrossRef

47.

Lopez-Legarrea P, De La Iglesia R, Crejeiras AB et al (2014) Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia af- ter weight loss in obese subjects. Nutr Diabetes 4:e110. https://doi.org/10.1038/nutd.2014.7 CrossRefPubMedPubMedCentral

48.

Gannon NP, Vaughan RA, Garcia-Smith R, Bisoffi M, Trujillo KA (2015) Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int J Cancer 136:E197–E202. https://doi.org/10.1002/ijc.29142 CrossRefPubMed

49.

Ebert T, Focke D, Petroff D et al (2014) Serum levels of the myokine irisin in relation to metabolic and renal function. Eur J Endocrinol 170:501–506. https://doi.org/10.1530/EJE-13-1053 CrossRefPubMed

50.

Phillips C, Baktir MA, Srivatsan M, Salehi A (2014) Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling. Front Cell Neurosci 8:170. https://doi.org/10.3389/fncel.2014.00170 CrossRefPubMedPubMedCentral

51.

Tremolizzo L, Pellegrini A, Conti E et al (2016) BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis. Neurodegener Dis 16:192–198. https://doi.org/10.1159/000441916 CrossRefPubMed

Titel: Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status
verfasst von: Christian Lunetta
Andrea Lizio
Lucio Tremolizzo
Massimiliano Ruscica
Chiara Macchi
Nilo Riva
Patrick Weydt
Ettore Corradi
Paolo Magni
Valeria Sansone
Publikationsdatum: 22.10.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 12/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-018-9093-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status

Abstract

Introduction

Objectives

Methods

Results

Conclusions

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie

Springer Medizin

Abstract

Introduction

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2018

Structural signature in SCA1: clinical correlates, determinants and natural history

Link between overweight/obese in children and youngsters and occurrence of multiple sclerosis

Migraine prophylactic management in neurology and primary care (2006–2015)

The role of clinical and neuroimaging features in the diagnosis of CADASIL

Effect of mechanical thrombectomy alone or in combination with intravenous thrombolysis for acute ischemic stroke

Generalization after ocular onset in myasthenia gravis: a case series in Germany

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie